COVID PAGE BLOX | Newman Regional Health

Tier 3 visitation restrictions are currently in place, please review before coming to the facility.

COVID-19 VACCINATIONS

Individuals 5 years of age and older are eligible for COVID-19 vaccinations at Newman Regional Health by appointment. 3rd and boost doses of the Moderna and Janssen COVID-19 vaccines for all eligible individuals in addition to continuing administration of the Pfizer-BioNTech vaccine.

Schedule an appointment:

Call the COVID-19 vaccine scheduling help center at (620) 343-6801 Monday thru Friday from 8:00am to 4:30pm.
During a visit with a primary care provider.
By filling out a COVID-19 Vaccination/Test Appointment request

Scheduling Hotline
(620) 343-6801

COVID-19 Vaccine/Test Appointment

Vaccines.gov

COVID-19 TESTING

Newman Regional Health provides COVID-19 Testing Monday thru Friday. Nasal swab testing only, by appointment.
To schedule: (620) 343-6801

COVID-19 AND PREGNANCY

If you are pregnant, plan to become pregnant, or are breastfeeding, review frequently asked questions about the COVID-19 vaccine.
https://www.onevaxtwolives.com/

Dr. Deshala Castille speaks about being vaccinated while she was pregnant and Dr. Symmonds talks about being vaccinated and nursing her child.

COVID-19 Vaccines Authorized in the United States
	Pfizer-BioNTech		Moderna	Janssen (J&J)
Vaccine type	mRNA		mRNA	viral vector
Authorized age groups	5 – 11 years	≥12 years	≥ 18 years	≥ 18 years
Number of doses in initial series	2	2	2	1
Interval between doses in initial series	21 days	21 days	28 days	n/a
Dose volume	0.2 mL pediatric formula	0.3 mL	0.5 mL	0.5 mL
FDA status	Emergency Use Authorization	Approved	Emergency Use Authorization	Emergency Use Authorization


Individuals may receive influenza and any other vaccines at the same time as a COVID-19 vaccine.


	Pfizer-BioNTech		Moderna	Janssen (J&J)
Authorized booster	yes		yes	yes
Interval between initial series and booster	5 months		6 months	2 months
Dose volume	0.3 mL		0.25 mL	0.5
Individuals qualifying for booster	≥ 12 years old		≥ 18 years old	≥ 18 years old
FDA status	Emergency Use Authorization		Emergency Use Authorization	Emergency Use Authorization
Heterologous (or “mix and match”) booster doses are allowed following the eligibility requirements of the individual’s primary COVID-19 vaccine.


	Pfizer-BioNTech		Moderna	Janssen (J&J)
Authorized 3rd dose	yes		yes	n/a
Interval between initial series and 3rd dose	28 days		28 days	n/a
Dose volume	0.3 mL		0.5 mL	n/a
Individuals qualifying for 3rd dose	≥5 years		≥ 18 years	n/a
	Moderate or severely immunocompromised individuals:		Moderate or severely immunosuppressed individuals:	n/a
	Receiving active cancer treatment for tumors or cancers of the blood		Receiving active cancer treatment for tumors or cancers of the blood
	Received an organ transplant and are taking medicine to suppress the immune system		Received an organ transplant and are taking medicine to suppress the immune system
	Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system		Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system
	Have moderate or severe primary immunodeficiency (such as DiGeorge syndrome or Wiskott-Aldrich syndrome)		Have moderate or severe primary immunodeficiency (such as DiGeorge syndrome or Wiskott-Aldrich syndrome)
	Have advanced HIV infection (high viral load or low CD4 count)or untreated HIV infection		Have advanced HIV infection (high viral load or low CD4 count)or untreated HIV infection
	Active treatment with high-dose corticosteroids or other drugs that may suppress immune response		Active treatment with high-dose corticosteroids or other drugs that may suppress immune response
FDA status	Emergency Use Authorization		Emergency Use Authorization	n/a
Additional 3rd doses should be the same vaccine type as the individual’s primary COVID-19 vaccine if available.

Schedule an appointment:

Connect With Us